-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is not clear whether the time from venous thrombosis (IVT) to intravascular therapy (EVT) in patients with acute ischemic stroke has an effect on the outcome of the patient's function.
recently, an authoritative journal in the field of neurology, Annals of Neurology, published a research article on the subject.
ischemic stroke vascular therapy (ETIS study) is an ongoing, forward-looking, multi-center, observational study in which subjects received EVT in France.
researchers analyzed data on patients treated with IVT and EVT at six comprehensive stroke centers from October 2013 to December 2018.
preliminary analysis, the researchers assessed the correlation between IVT dosing and functional outcomes (measured by the improved Rankin scale (mRS) from IVT dosing to EVT start time and functional outcomes using the sequence Logistic regression.
the study included angiotomy and safety outcomes.
researchers analyzed 1986 patients with acute ischemic stroke who had IVT and EVT due to precirculation of large blood vessels.
the extension of EVT to IVT time at the beginning of the patient's 90-day poor functional outcome (mRS is 0-2, and the correction ratio for each additional 30 minutes is 0.91 (95 percent) than the ratio of .aOR. CI is 0.86 to 0.96, mRS is 0-1, and aOR is 0.89 for every 30 minutes added .95% CI is 0.84 to 0.94).
results provide a basis for further exploration of whether the functional prognostication of stroke patients can be optimized from IVT to EVT time.
。